This manuscript represents a review of lymphoblastic leukemia/lymphoma (acute
lymphoblastic leukemia/lymphoblastic lymphoma), acute leukemias of ambiguous lineage …

Despite progress in the upfront treatment of diffuse large B cell lymphoma (DLBCL), patients
still experience relapses. Salvage chemotherapy followed by autologous stem cell …

Lymphoplasmacytic lymphoma involving the bone marrow can be difficult to diagnose, and
pathological features that predict the presence of associated Waldenström's …

An increased white blood cell count, or leukocytosis, is a common laboratory finding.
Appropriate specimen evaluation depends on which lineages are increased and the …

Purpose The objective is to assess the role of 18 F-2-fluoro-2-deoxy-D-glucose (FDG)
positron emission tomography (PET)/CT versus bone marrow biopsy (BMB) in the initial …

Bone marrow involvement in lymphoma may have prognostic and therapeutic
consequences. Bone marrow biopsy (BMB) is the established method for the evaluation of …

Leukocytosis, or elevated WBC count, is a commonly encountered laboratory finding.
Distinguishing malignant from benign leukocytosis is a critical step in the care of a patient …

In situ follicular neoplasia (ISFN) is the earliest morphologically identifiable precursor of
follicular lymphoma (FL). Although it is genetically less complex than FL and has low risk for …

Despite advances in the development of clinical agents for treating Mantle Cell Lymphoma
(MCL), treatment of MCL remains a challenge due to complexity and frequent relapse …

Aims This study aimed to evaluate the key features of bone marrow trephine (BMT) biopsy
involvement by lymphoma. Methods 511 cases were assessed for percentage of marrow …